-
1.
公开(公告)号:US20240207213A1
公开(公告)日:2024-06-27
申请号:US18556006
申请日:2022-04-18
发明人: Jeffrey HUBBELL , Shijie CAO , Michal RACZY , Elyse WATKINS , Erica BUDINA
IPC分类号: A61K31/221 , A61K9/00 , A61P37/00
CPC分类号: A61K31/221 , A61K9/0053 , A61P37/00
摘要: Described herein are novel methods of treating disorders using oral, systemically bioavailable forms of butyrate. Aspects of the disclosure relate to a method for treating a disorder in a subject comprising administering the oral, systemically bioavailable composition to the subject, wherein the disorder is selected from inflammatory bowel disease (IBD), multiple sclerosis (MS), a neuroinflammatory condition, food allergies, rheumatoid arthritis (RA), asthma, celiac disease, non-alcoholic steatohepatitis (NASH), diabetes, Alzheimer's disease (AD), inflammaging, beta-hemoglobinopathies, vascular inflammatory conditions, atopic dermatitis and psoriasis, pulmonary fibrosis, and systemic sclerosis.